Medicare Enrolled
Dr. Tom Macek, MD
Interventional Pain Medicine Physician · Oakland Park, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Macek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macek? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Macek
Dr. Tom Macek is an interventional pain medicine physician in Oakland Park, FL, with 19 years in practice. Based on federal Medicare data, Dr. Macek performed 7,973 Medicare services across 2,329 unique beneficiaries.
Between the years covered by Open Payments, Dr. Macek received a total of $13,296 from 50 pharmaceutical and/or device companies across 800 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Macek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 17% volume in FL$ $13,296 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,973
Medicare services
Top 17% in FL for interventional pain medicine physician
2,329
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~420 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,410 | $0 | $5 |
| Office visit, established patient (20-29 min) | 1,071 | $70 | $180 |
| Drug screening test | 853 | $61 | $200 |
| Injection, methylprednisolone acetate, 80 mg | 590 | $9 | $25 |
| Injection, methylprednisolone acetate, 40 mg | 511 | $6 | $25 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 453 | $195 | $615 |
| Office visit, established patient (30-39 min) | 322 | $97 | $251 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 241 | $210 | $340 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 238 | $111 | $180 |
| Ultrasonic guidance for needle placement | 196 | $47 | $110 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 174 | $228 | $370 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 173 | $118 | $190 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 145 | $28 | $70 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 133 | $280 | $480 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 129 | $129 | $220 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 123 | $169 | $445 |
| Manual therapy (hands-on treatment), per 15 min | 93 | $22 | $61 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 85 | $534 | $860 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 85 | $292 | $470 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 84 | $57 | $85 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 83 | $70 | $422 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 72 | $84 | $172 |
| Injection, ketorolac tromethamine, per 15 mg | 69 | $1 | $23 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 67 | $106 | $500 |
| Acupuncture with electrical stimulation, initial 15 minutes | 63 | $37 | $128 |
| Acupuncture with electrical stimulation, each additional 15 minutes | 63 | $30 | $109 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 61 | $527 | $850 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 61 | $309 | $500 |
| Annual depression screening | 58 | $19 | $40 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 50 | $238 | $618 |
| New patient office visit (45-59 min) | 40 | $132 | $320 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 39 | $32 | $50 |
| Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | 27 | $39 | $100 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 21 | $292 | $520 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | 21 | $148 | $260 |
| Office visit, established patient (10-19 min) | 18 | $44 | $110 |
| Remote patient monitoring device, 30 days | 13 | $39 | $55 |
| Remote patient monitoring management, 20 min/month | 13 | $39 | $60 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 13 | $35 | $65 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $107 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,296
Total received (2018-2024)
Avg $1,899/year across 7 years
Top 19% in FL for interventional pain medicine physician
50
Companies
800
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,296 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,395
2023$1,671
2022$2,323
2021$2,176
2020$2,106
2019$1,948
2018$1,677
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,334
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,153
ABBVIE INC.
$1,132
Collegium Pharmaceutical, Inc.
$1,129
Scilex Pharmaceuticals Inc.
$523
SCILEX PHARMACEUTICALS INC.
$452
Zyla Life Sciences
$418
Egalet US Inc
$399
PFIZER INC.
$381
Nevro Corp.
$358
BioDelivery Sciences International, Inc.
$345
Allergan Inc.
$275
Horizon Therapeutics plc
$235
RedHill Biopharma Inc.
$216
Orexo US, Inc.
$192
Boston Scientific Corporation
$170
Zyla Life Sciences, Inc.
$150
Amneal Pharmaceuticals LLC
$120
IBSA Pharma Inc.
$103
Medtronic USA, Inc.
$89
Medtronic, Inc.
$89
Biohaven Pharmaceutical Holding Company Ltd.
$89
Daiichi Sankyo Inc.
$79
AstraZeneca Pharmaceuticals LP
$77
Teva Pharmaceuticals USA, Inc.
$70
Lilly USA, LLC
$66
Purdue Pharma L.P.
$64
Allergan, Inc.
$51
Pernix Therapeutics Holdings, Inc.
$49
Nuvectra Corporation
$46
AbbVie Inc.
$46
Stimwave Technologies Incorporated
$33
Shionogi Inc
$32
Nalu Medical, Inc.
$29
Kaleo, Inc.
$28
Sentynl Therapeutics, Inc.
$27
GRT US Holding, Inc.
$23
Assertio Therapeutics, Inc.
$22
Virtus Pharmaceuticals LLC
$21
DePuy Synthes Sales Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$19
Biohaven Pharmaceuticals, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$19
Siemens Medical Solutions USA, Inc.
$19
Avion Pharmaceuticals
$16
Horizon Pharma plc
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Forte Bio-Pharma LLC
$13
Vertiflex, Inc.
$12
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 49.8% of total payments
Associated products mentioned in payments ›
ARYMO ER · AUSTEDO · Algovita · Austedo XR · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · COMIRNATY · Cios Select · DUEXIS · EMGALITY · EVZIO · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · INTELLIS · INTELLIS ADAPTIVESTIM · Kloxxado · LEVORPHANOL TARTRATE · LICART · LIDOCAINE HYDROCHLORIDE · LYRICA · LYVISPAH · Levorphanol · Levorphanol Tartrate · MOVANTIK · Morphabond ER · Movantik · NP Thyroid 60 · NURTEC ODT · Nalocet · Nalu Neurostimulation System · ORTHOVISC · Omnia · PENNSAID · PROCLAIM · PRODIGY · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRIX · SYMPROIC · SYNCHROMED · Seglentis · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion ISS · Symproic · Tirosint · UBRELVY · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZIPSOR · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $167 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
31
Per 100K population
1.6
County median income
$74,534
Nearest hospital
FORT LAUDERDALE BEHAVIORAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Macek is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Macek experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Macek performed 1,410 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macek receive payments from pharmaceutical companies?
Yes. Dr. Macek received a total of $13,296 from 50 companies across 800 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macek's costs compare to other interventional pain medicine physicians in Oakland Park?
Dr. Macek's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Oakland Park
Browse interventional pain medicine physicians in Oakland Park ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology